Senior insider sale
President and Chairman at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$56.5K
10.81K shares
What this filing means
GAD THOMAS plans to sell 10.81K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $56.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/7/2025ACC: 0001964306-25-000142
DirectorOfficer· President and Chairman
Since Sep 2018
10.81K
Shares to sell
$56.5K
Approx. market value
10.81K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
1/18/2025
3.82KVesting of restricted stock unit award
Granted as part of issuer equity compensation plan
1/17/2025
6.99KTotal acquired10.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/18/2025 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 3.82K | — |
1/17/2025 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 6.99K | — |
| Total | 10.81K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10.81K
Market value
$56.5K
3/7/2025
Total
Units
10.81K
Value
$56.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/7/2025 | 10.81K | $56.5K | NASDAQ | Planned |
| Total | 10.81K | $56.5K | ||